Clinical Trials on Type1diabetes in Norway
Total 0 results
Nothing found
Sponsors and Collaborators
- Bjørgene Omsorgssenter, Haugesund
- Prestige Biopharma Limited
- Chengdu Nuoen Biotechnologies, Inc.
- North Karelia Hospital District
- Grand Challenges Canada
- Bruce County Paramedic Service
- Neuregenix
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- AIDS Council of New South Wales
- Reina Sofia University Hospital
- Nestor Soler Porcar, MD, PhD
- ImproveCareNow (ICN)
- InflaRx GmbH
- Women and children's hospital of Jiaxing university
- Veeda Oncology
- BayCare Health System
- Mononuclear Therapeutics Ltd.
- Equipe MiMes
- Centro di Procreazione Assistita Demetra
- Maria Lendorf
- View Full List
Medical Conditions
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Tay-Sachs Disease Ganglioside
- Skull Base Neoplasms
- Psoriasis, Arthritic
- Chlamydophila Infections
- Painless Hysteroscopy
- Ewing's Family Tumors
- Endocarditis Infective
- Fracture Dislocation of Cervical Spine
- Closure; Foramen Ovale
- Gullian Barre Syndrome
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Epidemic Hemorrhagic Fever
- Multisystem Proteinopathy
- Pulmonary Adenocarcinoma
- Childhood Langerhans Cell Histiocytosis
- Predictors of Atrial Fibrillation Recurrences
- Spine Surgeries
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Fetus or Neonate Affected by External Version Before Labor
- View Full List
Drug Interventions
- Palliative care group first-line scheme
- High dose pantoprazole infusion
- Qingkailing injection 40 ml
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- Chemotherapeutic Agent
- Cereport
- Neihulizumab
- Glimepiride
- Semapimod
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Vehicle
- EFV +TVA
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Azelastine hydrochloride (BAYR9258)
- Adriamycin
- Adapalene Gel 0.3%
- Estradiol+Drospirenone
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- View Full List
CROs by country
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Finland
- Contract Research Organizations in Greece
- Contract Research Organizations in Guinea
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Israel
- Contract Research Organizations in Japan
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Uganda
- CRO list by country